JAN 20, 2019 4:13 PM PST

Multiple sclerosis treatments hold long-term benefits

WRITTEN BY: Nouran Amin

An international study, led by the Clinical Outcomes Research unit (CORe) at Royal Melbourne Hospital and University of Melbourne, concludes the importance of early treatments of multiple sclerosis (particularly within the first five years of onset) holds extensive long-term benefits.

Learn more about Multiple Sclerosis (MS):

The study was the first to provide evidence that current drug treatments delay the progression of multiple sclerosis (MS) into its secondary stage which is described by an ongoing increase of disability involving the worsening of physical and mental capacity as well as the reduced quality of life. The crucial need to delay the progression represents an important outcome for individuals living with multiple sclerosis.

The research generated data from 1555 patients at 68 neurological clinics across 21 countries and highlighted the importance to treat MS pro-actively.

Multiple sclerosis is a condition characterized by areas of damage on the brain. This damage affects the covering that protects nerves (the myelin sheath).

Credit: NIH Genetics Home Reference

"People who converted from relapsing MS to secondary progressive MS experience gradual and mostly irreversible worsening of disability,” said Associate Professor and head of the MS Service at The Royal Melbourne Hospital and CORe at the University of Melbourne, Tomas Kalincik."Most of the therapies that we use to treat MS have no effect once people have converted to secondary progressive MS. This study shows us how important it is to treat relapsing MS early and pro-actively," Associate Professor Kalincik said.

Results of the study, in collaboration with the University of Cambridge, were published in the international medical journal, JAMA. Associate Professor Kalincik believes that the results are reassuring neurologists and patients with MS. He states, "This study shows that the therapies they have been treated with for many years, significantly improve the quality of their lives over the long-term.”

Source: The Royal Melbourne Hospital

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 19, 2021
Drug Discovery & Development
Combination Immunotherapy Shows Promise in Treating HIV
MAY 19, 2021
Combination Immunotherapy Shows Promise in Treating HIV
  Researchers have found that a new combination immunotherapy, alongside antiretroviral therapy (ART), is effective ...
JUN 01, 2021
Cannabis Sciences
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
JUN 01, 2021
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 09, 2021
Drug Discovery & Development
New Drug Prevents Dementia After Head Injury
JUN 09, 2021
New Drug Prevents Dementia After Head Injury
Researchers led by the University of South Australia have identified a new drug that may be able to help prevent athlete ...
JUL 18, 2021
Drug Discovery & Development
COVID-19 Antibiotic No More Effective than Placebo
JUL 18, 2021
COVID-19 Antibiotic No More Effective than Placebo
Azithromycin, a broad-spectrum antibiotic commonly used to prevent symptoms of COVID-19 in non-hospitalized patients, do ...
JUL 27, 2021
Immunology
Rethinking Immune Responses Involved in Skin Hypersensitivity
JUL 27, 2021
Rethinking Immune Responses Involved in Skin Hypersensitivity
A study by immunologists at the University of Copenhagen has revealed a never-before-seen immune pathway invol ...
Loading Comments...